These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 10999244)

  • 21. Course and outcome of depressive disorders in primary care: a prospective 18-month study.
    Vuorilehto MS; Melartin TK; Isometsä ET
    Psychol Med; 2009 Oct; 39(10):1697-707. PubMed ID: 19250580
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Efficacy and tolerability of escitalopram versus citalopram in major depressive disorder: a 6-week, multicenter, prospective, randomized, double-blind, active-controlled study in adult outpatients.
    Yevtushenko VY; Belous AI; Yevtushenko YG; Gusinin SE; Buzik OJ; Agibalova TV
    Clin Ther; 2007 Nov; 29(11):2319-32. PubMed ID: 18158074
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Long-term follow-up after successful electroconvulsive therapy for depression: a 4- to 8-year naturalistic follow-up study.
    van Beusekom BS; van den Broek WW; Birkenhäger TK
    J ECT; 2007 Mar; 23(1):17-20. PubMed ID: 17435567
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Selegiline transdermal system in the prevention of relapse of major depressive disorder: a 52-week, double-blind, placebo-substitution, parallel-group clinical trial.
    Amsterdam JD; Bodkin JA
    J Clin Psychopharmacol; 2006 Dec; 26(6):579-86. PubMed ID: 17110814
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A closer look at treatment resistant depression: is it due to a bipolar diathesis?
    Sharma V; Khan M; Smith A
    J Affect Disord; 2005 Feb; 84(2-3):251-7. PubMed ID: 15708423
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Long term outcome of primary care depression.
    Yiend J; Paykel E; Merritt R; Lester K; Doll H; Burns T
    J Affect Disord; 2009 Nov; 118(1-3):79-86. PubMed ID: 19246103
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Clinical characteristics and treatment outcome in a representative sample of depressed inpatients - findings from the Munich Antidepressant Response Signature (MARS) project.
    Hennings JM; Owashi T; Binder EB; Horstmann S; Menke A; Kloiber S; Dose T; Wollweber B; Spieler D; Messer T; Lutz R; Künzel H; Bierner T; Pollmächer T; Pfister H; Nickel T; Sonntag A; Uhr M; Ising M; Holsboer F; Lucae S
    J Psychiatr Res; 2009 Jan; 43(3):215-29. PubMed ID: 18586274
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Relapse during a 6-month continuation treatment with fluvoxamine in an Italian population: the role of clinical, psychosocial and genetic variables.
    Dotoli D; Spagnolo C; Bongiorno F; Zanardi R; Serretti A; Smeraldi E; Franchini L
    Prog Neuropsychopharmacol Biol Psychiatry; 2006 May; 30(3):442-8. PubMed ID: 16431008
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Remission and relapse after the first hospital admission in psychotic depression: a 4-year naturalistic follow-up.
    Naz B; Craig TJ; Bromet EJ; Finch SJ; Fochtmann LJ; Carlson GA
    Psychol Med; 2007 Aug; 37(8):1173-81. PubMed ID: 17335639
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Long-term naturalistic follow-up of lithium augmentation: relevance to bipolarity.
    Inoue T; Abekawa T; Nakagawa S; Suzuki K; Tanaka T; Kitaichi Y; Boku S; Nakato Y; Toda H; Koyama T
    J Affect Disord; 2011 Mar; 129(1-3):64-7. PubMed ID: 20837361
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Time course of response to antidepressants: predictive value of early improvement and effect of additional psychotherapy.
    van Calker D; Zobel I; Dykierek P; Deimel CM; Kech S; Lieb K; Berger M; Schramm E
    J Affect Disord; 2009 Apr; 114(1-3):243-53. PubMed ID: 18849079
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Evolution of depression in the child and adolescent].
    Bouvard MP; Paris P; Dugas M
    Encephale; 1993 Aug; 19 Spec No 3():473-9. PubMed ID: 8299546
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Propagation of major depressive disorder: relationship between first episode symptoms and recurrence.
    Pettit JW; Lewinsohn PM; Joiner TE
    Psychiatry Res; 2006 Mar; 141(3):271-8. PubMed ID: 16497387
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A randomized, double-blind comparison of duloxetine and venlafaxine in the treatment of patients with major depressive disorder.
    Perahia DG; Pritchett YL; Kajdasz DK; Bauer M; Jain R; Russell JM; Walker DJ; Spencer KA; Froud DM; Raskin J; Thase ME
    J Psychiatr Res; 2008 Jan; 42(1):22-34. PubMed ID: 17445831
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Eighteen months of drug treatment for depression: predicting relapse and recovery.
    Mulder RT; Frampton CM; Luty SE; Joyce PR
    J Affect Disord; 2009 Apr; 114(1-3):263-70. PubMed ID: 18805590
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Duration of untreated illness in major depressive disorder: a naturalistic study.
    Altamura AC; Dell'Osso B; Mundo E; Dell'Osso L
    Int J Clin Pract; 2007 Oct; 61(10):1697-700. PubMed ID: 17877655
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Compliance with antidepressants in a primary care setting, 2: the influence of gender and type of impairment.
    Demyttenaere K; Enzlin P; Dewé W; Boulanger B; De Bie J; De Troyer W; Mesters P
    J Clin Psychiatry; 2001; 62 Suppl 22():34-7. PubMed ID: 11599646
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Treatment of depressive disorders with and without medication - a naturalistic study.
    Hasler G; Schnyder U; Klaghofer R; Angst J
    Pharmacopsychiatry; 2002 Nov; 35(6):235-8. PubMed ID: 12518272
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A New Empirical Definition of Major Depressive Episode Recovery and Its Positive Impact on Future Course of Illness.
    Judd LL; Schettler PJ; Rush AJ; Coryell WH; Fiedorowicz JG; Solomon DA
    J Clin Psychiatry; 2016 Aug; 77(8):1065-73. PubMed ID: 26580150
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Relationship between baseline severity of depression and antidepressant treatment outcome.
    Henkel V; Seemüller F; Obermeier M; Adli M; Bauer M; Kronmüller K; Holsboer F; Brieger P; Laux G; Bender W; Heuser I; Zeiler J; Gaebel W; Mayr A; Riedel M; Möller HJ
    Pharmacopsychiatry; 2011 Jan; 44(1):27-32. PubMed ID: 20981642
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.